3-Nitropropionic Acid Enhances Ferroptotic Cell Death via NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin
Biological and Pharmaceutical Bulletin · 2023
DOI: 10.1248/bpb.b22-00529 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2023. Verfasst von Noria Okada und 2 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Huntington Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University.
Zitieren
APA
Okada, N., Nakamura, S., & Shimazawa, M. (2023). 3-Nitropropionic Acid Enhances Ferroptotic Cell Death via NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b22-00529
Vancouver
Okada N, Nakamura S, Shimazawa M. 3-Nitropropionic Acid Enhances Ferroptotic Cell Death via NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin. Biological and Pharmaceutical Bulletin. 2023. doi:10.1248/bpb.b22-00529
BibTeX
@article{Okada2023,
author = {Okada, Noria and Nakamura, Shinsuke and Shimazawa, Masamitsu},
title = {3-Nitropropionic Acid Enhances Ferroptotic Cell Death via NOX2-Mediated ROS Generation in STHdhQ111 Striatal Cells Carrying Mutant Huntingtin},
journal = {Biological and Pharmaceutical Bulletin},
year = {2023},
doi = {10.1248/bpb.b22-00529}
}
EUVIMED